- Home
- APRE vs LCFY Comparison
APRE vs LCFY Comparison
Compare APRE & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- LCFY
- Stock Information
- Founded
- APRE 2006
- LCFY 2009
- Country
- APRE United States
- LCFY Australia
- Employees
- APRE N/A
- LCFY N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- LCFY
- Sector
- APRE Health Care
- LCFY
- Exchange
- APRE Nasdaq
- LCFY Nasdaq
- Market Cap
- APRE 8.3M
- LCFY 9.2M
- IPO Year
- APRE 2019
- LCFY 2022
- Fundamental
- Price
- APRE $1.47
- LCFY $5.47
- Analyst Decision
- APRE Strong Buy
- LCFY
- Analyst Count
- APRE 1
- LCFY 0
- Target Price
- APRE $20.00
- LCFY N/A
- AVG Volume (30 Days)
- APRE 40.4K
- LCFY 143.9K
- Earning Date
- APRE 11-06-2025
- LCFY 11-11-2025
- Dividend Yield
- APRE N/A
- LCFY N/A
- EPS Growth
- APRE N/A
- LCFY N/A
- EPS
- APRE N/A
- LCFY N/A
- Revenue
- APRE $841,012.00
- LCFY $2,231,313.00
- Revenue This Year
- APRE N/A
- LCFY N/A
- Revenue Next Year
- APRE N/A
- LCFY N/A
- P/E Ratio
- APRE N/A
- LCFY N/A
- Revenue Growth
- APRE N/A
- LCFY N/A
- 52 Week Low
- APRE $1.37
- LCFY $2.51
- 52 Week High
- APRE $5.01
- LCFY $13.98
- Technical
- Relative Strength Index (RSI)
- APRE 45.12
- LCFY 39.77
- Support Level
- APRE $1.46
- LCFY $7.07
- Resistance Level
- APRE $1.57
- LCFY $7.67
- Average True Range (ATR)
- APRE 0.08
- LCFY 0.82
- MACD
- APRE 0.01
- LCFY -0.13
- Stochastic Oscillator
- APRE 54.45
- LCFY 38.53
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.